# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA1114213 | F | Antiviral activity against Human coxsackievirus B4 infected in human HeLa cells assessed as protection from virus-induced cytopathogenicity after 2 days by MTT assay | Coxsackievirus B4 | 8 | organism-based format | Scientific Literature | ||
2. | ALA1114214 | F | Antiviral activity against Reovirus 1 infected in african green monkey Vero cells assessed as protection from virus-induced cytopathogenicity after 6 to 7 days by MTT assay | Mammalian orthoreovirus 1 | 8 | organism-based format | Scientific Literature | ||
3. | ALA1114215 | F | Antiviral activity against VSV infected in human HeLa cells assessed as protection from virus-induced cytopathogenicity after 1 to 2 days by MTT assay | Vesicular stomatitis virus | 8 | organism-based format | Scientific Literature | ||
4. | ALA1114216 | F | Antibacterial activity against Streptococcus viridans after 24 hrs by broth microdilution method | Streptococcus viridans | 8 | organism-based format | Scientific Literature | ||
5. | ALA1114217 | F | Antibacterial activity against Escherichia coli after 24 hrs by broth microdilution method | Escherichia coli | 8 | organism-based format | Scientific Literature | ||
6. | ALA1114218 | F | Antibacterial activity against Klebsiella pneumoniae after 24 hrs by broth microdilution method | Klebsiella pneumoniae | 8 | organism-based format | Scientific Literature | ||
7. | ALA1114219 | F | Antibacterial activity against Proteus mirabilis after 24 hrs by broth microdilution method | Proteus mirabilis | 8 | organism-based format | Scientific Literature | ||
8. | ALA1114220 | F | Antiviral activity against Respiratory syncytial virus infected in human HeLa cells assessed as protection from virus-induced cytopathogenicity after 4 days by MTT assay | Respiratory syncytial virus | 8 | organism-based format | Scientific Literature | ||
9. | ALA1115015 | F | Antiviral activity against Herpes simplex virus 1 KOS infected in HEL cells assessed as protection from virus-induced cytopathogenicity after 2 to 3 days by MTT assay | Human alphaherpesvirus 1 | 9 | organism-based format | Scientific Literature | ||
10. | ALA1115016 | F | Antiviral activity against Herpes simplex virus 2 G infected in HEL cells assessed as protection from virus-induced cytopathogenicity after 2 to 3 days by MTT assay | Human alphaherpesvirus 2 | 9 | organism-based format | Scientific Literature | ||
11. | ALA1115017 | F | Antiviral activity against Vaccinia virus infected in HEL cells assessed as protection from virus-induced cytopathogenicity after 2 to 3 days by MTT assay | Vaccinia virus | 9 | organism-based format | Scientific Literature | ||
12. | ALA1115018 | F | Antiviral activity against VSV infected in HEL cells assessed as protection from virus-induced cytopathogenicity after 1 to 2 days by MTT assay | Vesicular stomatitis virus | 9 | organism-based format | Scientific Literature | ||
13. | ALA1115019 | F | Antiviral activity against acyclovir-sensitive Herpes simplex virus 1 KOS infected in HEL cells assessed as protection from virus-induced cytopathogenicity after 2 to 3 days by MTT assay | Human alphaherpesvirus 1 | 9 | organism-based format | Scientific Literature | ||
14. | ALA1115020 | F | Antiviral activity against PIV 3 infected in african green monkey Vero cells assessed as protection from virus-induced cytopathogenicity after 6 to 7 days by MTT assay | Human respirovirus 3 | 8 | organism-based format | Scientific Literature | ||
15. | ALA1115021 | F | Antiviral activity against Sindbis virus infected in african green monkey Vero cells assessed as protection from virus-induced cytopathogenicity after 2 to 3 days by MTT assay | Sindbis virus | 8 | organism-based format | Scientific Literature | ||
16. | ALA1115022 | F | Antiviral activity against Human coxsackievirus B4 infected in african green monkey Vero cells assessed as protection from virus-induced cytopathogenicity after 2 days by MTT assay | Coxsackievirus B4 | 8 | organism-based format | Scientific Literature | ||
17. | ALA1115023 | F | Antiviral activity against Punta Toro virus infected in african green monkey Vero cells assessed as protection from virus-induced cytopathogenicity by MTT assay | Punta Toro virus | 8 | organism-based format | Scientific Literature | ||
18. | ALA1115024 | F | Antiviral activity against Feline coronavirus infected in cat CRFK cells assessed as protection from virus-induced cytopathogenicity by MTT assay | Feline coronavirus | 7 | organism-based format | Scientific Literature | ||
19. | ALA1115025 | F | Antiviral activity against Feline herpesvirus infected in cat CRFK cells assessed as protection from virus-induced cytopathogenicity by MTT assay | Felid alphaherpesvirus 1 | 7 | organism-based format | Scientific Literature | ||
20. | ALA1115026 | F | Antiviral activity against Influenza A virus H1N1 infected in MDCK cells assessed as protection from virus-induced cytopathogenicity after 6 to 7 days by MTT assay | Influenza A virus | 7 | organism-based format | Scientific Literature |